Red Flag: Providers who prescribe without any consultation or who approve everyone regardless of medical history are not practicing appropriate medicine
Key highlights Tirzepatide is the first dual GLP-1/GIP receptor agonist that offers stronger appetite suppression, improved glycemic control, and provides significantly greater weight loss than single receptor agonists such as semaglutide, liraglutide, and dulaglutide
You may notice an increase in appetite and a return of food cravings, allowing you to eat more without feeling as full
Sembolic Injection is normally given once a week subcutaneously under the skin of the abdomen, thigh, or upper arm, exactly as suggested by a doctor
Most recently, Serena Williams partnered with a digital healthcare company to promote GLP-1 weight loss medications, and several other celebs, including Jenna Bush Hager, Chrissy Teigen, and Eric Stonestreet, have been vocal with their support of these potentially life-changing medications